JPRN-UMIN000006635已完成3 期
Clinical study of Rituximab for inhibition of antibody mediated rejection in ABO-incompatible kidney transplantation - Clinical study of Rituximab in ABO-incompatible kidney transplantation
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 74years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) pregnant woman or lactating mothers 2) positive HBV serology(i.e., HBs antigen, HBs and/or HBc antibody), and positive HCV antibody 3) HIV infection 4) HTLV-1 infection 5) active infection of any kind
研究者
相似试验
进行中（未招募）
不适用
Efficacy of Rituximab treatment in patients with rheumatoid arthritis having inadequate response to TNF blockerTo investigate the efficacy of treatment with Rituximab (MabThera®) in patients with active RA whose current treatment with one or more TNF-blocker (Etanercept - Enbrel®, Infliximab – Remicade® or Adalimumab - Humira®) alone or in combination with MTX is insufficient measured by DAS28 activity index.EUCTR2006-004673-98-HURoche (Hungary) Ltd.20
未知
2 期
Clinical study for effectiveness of rituximab for acquired coagulopathyacquired coagulopathyJPRN-UMIN000024612Gunma University10
已完成
2 期
A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)Diffuse large B-cell lymphomaJPRN-UMIN000001050Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)40
已完成
不适用
Analysis of Rituximab intensification therapy for low grade B-cell lymphoma refractory to BendamustineJPRN-UMIN000007110Tokyo women's medical university50
招募中
不适用
Desensitization with rituximab for preformed anti-donor antibody and antibody-mediated rejection in kidney transplantation.end stage renal diseaseJPRN-UMIN000032113Hyogo College of Medicine90